名臣健康(002919) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥149,012,185.35, a decrease of 31.24% compared to ¥216,717,972.68 in the same period last year[3] - Net profit attributable to shareholders was ¥1,638,200.89, down 97.39% from ¥62,676,044.09 year-on-year[3] - The total operating profit for the first quarter was CNY 1,050,322.55, compared to CNY 63,385,335.93 in the previous year, indicating a decrease of about 98.3%[20] - The net profit for the first quarter of 2022 was CNY 1,638,200.89, a significant decrease from CNY 62,676,044.09 in the same period last year, reflecting a decline of approximately 97.4%[20] - The company's total comprehensive income for the first quarter was CNY 1,638,200.89, down from CNY 62,676,044.09 in the same period last year[21] - The company's basic and diluted earnings per share for the first quarter were both CNY 0.01, a decrease from CNY 0.51 in the previous year[21] Cash Flow - The net cash flow from operating activities was -¥70,501,835.42, representing a decline of 112.56% compared to -¥33,167,525.98 in the previous year[3] - The cash flow from operating activities showed a net outflow of CNY 70,501,835.42, worsening from a net outflow of CNY 33,167,525.98 in the previous year[24] - The total cash inflow from operating activities was CNY 165,458,573.09, down from CNY 196,712,464.26 year-over-year[24] - The cash flow from investing activities resulted in a net outflow of CNY 65,252,988.05, compared to a net outflow of CNY 17,304,670.41 in the previous year[24] - The cash and cash equivalents at the end of the period were CNY 114,077,895.54, down from CNY 147,257,380.50 at the end of the previous year[25] - Cash and cash equivalents at the end of Q1 2022 were RMB 114,077,895.54, down from RMB 250,898,429.01 at the beginning of the year[15] Assets and Liabilities - The company's total assets decreased by 2.38% to ¥947,253,566.02 from ¥970,345,939.68 at the end of the previous year[3] - Total assets as of March 31, 2022, were RMB 947,253,566.02, a decrease from RMB 970,345,939.68 at the beginning of the year[17] - Total liabilities decreased to RMB 187,804,716.52 from RMB 212,535,291.07 at the beginning of the year[17] Operating Costs and Margins - Total operating costs for Q1 2022 were RMB 142,910,650.51, down from RMB 152,956,064.09 in the previous period[19] - Gross profit margin for Q1 2022 was approximately 4.7%, compared to a higher margin in the previous period[19] Shareholder Information - The company has a total of 6,369 common shareholders as of the end of the reporting period[10] Investments and Acquisitions - The company plans to acquire 100% equity of Kashgar Aochu Network Technology Co., Ltd. for RMB 21,900,000, with a 30% deposit already paid[12] Financial Assets and Income - The company reported a significant increase in financial assets, with trading financial assets rising by 478.77% to ¥69,196,991.55[6] - Other income increased by 143.28% to ¥303,606.33, primarily due to an increase in government subsidies[7] - The company reported interest income of CNY 527,475.59, an increase from CNY 467,844.02 in the previous year[20] - The company incurred financial expenses of CNY -264,467.98, compared to CNY -74,761.37 in the same period last year[20] Research and Development - Research and development expenses for Q1 2022 were RMB 24,383,528.86, compared to RMB 22,359,923.96 in the previous period[19] Inventory and Accounts Receivable - Inventory at the end of Q1 2022 was RMB 134,643,845.68, slightly up from RMB 133,010,293.74 at the beginning of the year[15] - Accounts receivable increased to RMB 227,542,457.17 from RMB 209,736,137.63 at the beginning of the year[15] Credit Impairment - The company experienced a 345.61% increase in credit impairment losses, totaling -¥5,805,743.17, due to higher provisions for bad debts[7]